UroGen Pharma Ltd. Ordinary Shares (URGN) Stock Price Today & Analysis
URGN
Valuation
Market cap$880.01M
Price-to-sales ratio9.48
Price-to-book value-7.92
Price-earnings ratio-5.60
Return on Equity249.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-3.26
Income Statement
Average volume724,238
EBITDA$-144.14M
1 year high (52w)$30.00
1 year low (52w)$3.42
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About UroGen Pharma Ltd. Ordinary Shares
FAQ
You can easily purchase UroGen Pharma Ltd. Ordinary Shares (URGN) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'URGN' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in UroGen Pharma Ltd. Ordinary Shares with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
